Literature DB >> 4328344

Competitive binding assay for vitamin D and 25-OH vitamin D.

R Belsey, H F Deluca, J T Potts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4328344     DOI： 10.1210/jcem-33-3-554

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

1.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

Review 2.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

Review 3.  Vitamin D metabolism. Recent advances.

Authors:  T C Stamp
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

4.  Serum 25-hydroxy vitamin D in normal and osteomalacic subjects: a comparison of two assay techniques.

Authors:  B Murray; R Freaney
Journal:  Ir J Med Sci       Date:  1979-01       Impact factor: 1.568

5.  Effects of vitamin D metabolites and analogs on bone collagen synthesis in vitro.

Authors:  F R Bringhurst; J T Potts
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

6.  A rapid simplified method for plasma 25-hydroxyvitamin D estimation.

Authors:  J C Hamilton
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

7.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

Authors:  M R Hughes; D J Baylink; P G Jones; M R Haussler
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

8.  Significance of serum level of 25-hydroxycholecalciferol in gastrointestinal disease.

Authors:  M S Schoen; J Lindenbaum; M S Roginsky; P R Holt
Journal:  Am J Dig Dis       Date:  1978-02

9.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Abnormal vitamin D metabolism in patients with cirrhosis.

Authors:  G W Hepner; M Roginsky; H F Moo
Journal:  Am J Dig Dis       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.